Myelofibrosis - 46 Studies Found
| Active, not recruiting |
: Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis : Myelofibrosis : 2013-03-14 :
|
| Completed |
: Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis : Myelofibrosis : 2007-12-11 :
|
| Completed |
: A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis : Myelofibrosis : 2017-02-27 :
|
| Completed |
: Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients : Myelofibrosis : 2008-01-11 : Procedure: Allogeneic Stem Cell Transplantation Allogeneic Stem Cell Transplantation after dose-reduced |
| Completed |
: Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg : Myelofibrosis : 2016-03-08 :
|
| Terminated |
: A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial) : Primary Myelofibrosis : 2014-03-06 : Drug: Ruxolitinib Starting dose was based on reason for previous discontinuation of ruxolitinib (i.e. lo |
| Completed |
: Thalidomide in Treating Patients With Myelofibrosis : Primary Myelofibrosis : 2001-05-06 :
|
| Withdrawn |
: A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis : Primary Myelofibrosis : 2015-10-21 : Biological: Pacritinib QD (Once a day) |
| Active, not recruiting |
: Decitabine in Treating Patients With Myelofibrosis :
|
| Recruiting |
: P1101 in Treating Patients With Myelofibrosis :
|